185-79-5 Usage
General Description
3,3-Pentamethylenediazirine is a cyclic diazirine compound with the chemical formula C6H10N2. It is a highly reactive and unstable molecule that is used as a photolabeling reagent in biochemical research. When exposed to ultraviolet (UV) light, 3,3-Pentamethylenediazirine undergoes a photolytic reaction, producing a highly reactive carbene intermediate. This carbene can covalently crosslink with nearby proteins, nucleic acids, and other biomolecules, allowing researchers to study the interactions and structures of these molecules in living systems. 3,3-Pentamethylenediazirine is known for its application in studying protein-protein interactions, ligand-receptor binding, and the identification of protein binding sites and active sites. due to its photochemical behavior and its ability to form stable covalent bonds with biomolecules, 3,3-Pentamethylenediazirine is a valuable tool in the fields of biochemistry and chemical biology for investigating various biological processes and molecular interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 185-79-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,8 and 5 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 185-79:
(5*1)+(4*8)+(3*5)+(2*7)+(1*9)=75
75 % 10 = 5
So 185-79-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H12N2/c1-2-4-6(5-3-1)7-8-6/h7-8H,1-5H2
185-79-5Relevant articles and documents
-
Kato,Ohta
, p. 2048 (1962)
-
AGENTS FOR TREATING NEURODEGENERATIVE DISORDERS
-
Page/Page column 22, (2013/08/15)
The present invention relates to compounds of formula I, use of these compounds to treat mental and neurological disorders, especially depressions and psychoses of different etiology.. The compounds provided for the treatment of mental and neurological disorders are presented by a general formula I: wherein R, R', Y are as defined in specification or pharmaceutically acceptable salts thereof, solvates thereof such as hydrates, and pharmaceutical compositions containing such compounds.
